EcoDrugPlus

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 1

Ensembl ID : ENSOJAG00000019717
Gene Symbol: HSP90AA1.1
1 Cross references
330 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSOJAG00000018199
Gene Symbol: HSP90AB1
1 Cross references
339 Possible Orthologues:

High Mobility Group Box 1b

Ensembl ID : ENSOJAG00000010427
Gene Symbol: HMGB1B
1 Cross references
509 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSOJAG00000015323
Gene Symbol: HRH1
1 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSOJAG00000019508
Gene Symbol: HRH2
1 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSOJAG00000011427
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOJAG00000021222
Gene Symbol: HDAC1
1 Cross references
255 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOJAG00000020757
Gene Symbol: HDAC1
1 Cross references
250 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSOJAG00000009725
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSOJAG00000013868
Gene Symbol: HDAC11
1 Cross references
101 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSOJAG00000020960
Gene Symbol: HDAC2
1 Cross references
209 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSOJAG00000004660
Gene Symbol: HDAC4
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).